Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 10
Submit an article Journal homepage
175
Views
2
CrossRef citations to date
0
Altmetric
Letter

Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials

Daniela ZackovaDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech RepublicCorrespondence[email protected]
,
Hana KlamovaInstitute of Hematology and Blood Transfusion, Prague, Czech Republic
,
Jan MuzikInstitute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
,
Eduard CmuntGeneral University Hospital, Prague, Czech Republic
,
Zdenek RacilDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic;Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic
,
Katerina Machova PolakovaInstitute of Hematology and Blood Transfusion, Prague, Czech Republic
,
Dana DvorakovaDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic;Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic
,
Tomas JurcekDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
,
Filip RazgaDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
,
Petr CetkovskyInstitute of Hematology and Blood Transfusion, Prague, Czech Republic
,
Ladislav DusekInstitute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
&
Jiri MayerDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic;Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic
 show all
Pages 2310-2313 | Received 09 Nov 2012, Accepted 28 Jan 2013, Published online: 28 Feb 2013
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Acknowledgements

In particular, we thank Gabriela Vankova, Alexandra Oltova, Jana Brezinova and Kyra Michalova for cytogenetic analyses and data-managers Blanka Dobesova and Jana Rysava for data collection. We also thank Rich Zimmerman for his English text review and corrections.

Potential conflict of interest:

This work was supported by CELL – The CzEch Leukemia Study Group for Life. Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.